共 277 条
[1]
Lavanchy D(2011)Evolving epidemiology of hepatitis C virus Clin Microbiol Infect 17 107-115
[2]
Hanafiah KM(2013)Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence Hepatology 57 1333-1342
[3]
Groeger J(2014)Global epidemiology and genotype distribution of the hepatitis C virus infection J Hepatol 61 S45-S57
[4]
Flaxman AD(2015)New kids on the block-step by step to an ideal HCV therapy Lancet 385 1050-1052
[5]
Wiersma ST(2015)Electronic address eee: EASL recommendations on treatment of hepatitis C 2015 J Hepatol 63 199-236
[6]
Gower E(2015)Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable Gut 64 1190-1191
[7]
Estes C(2015)The cost-effectiveness of novel direct acting antiviral agent therapies for the treatment of chronic hepatitis C Expert Rev Pharmacoecon Outcomes Res. 15 787-800
[8]
Blach S(1999)Natural history of hepatitis C J Hepatol 31 17-24
[9]
Razavi-Shearer K(2011)Biomarkers of liver fibrosis J Gastroenterol Hepatol 26 802-809
[10]
Razavi H(2003)Sampling variability of liver fibrosis in chronic hepatitis C Hepatology 38 1449-1457